Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect

被引:1
作者
Ozbas-Turan, S. [1 ]
Akbuga, J. [1 ]
Enneli, B. [2 ]
机构
[1] Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey
[2] Yeditepe Univ, Fac Pharm, Istanbul, Turkey
来源
PHARMAZIE | 2009年 / 64卷 / 12期
关键词
POLYALKYLCYANOACRYLATE NANOPARTICLES; GENE DELIVERY; FORMULATION; SYSTEM; INHIBITION; CARRIERS; DNA;
D O I
10.1691/ph.2009.9193
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objective of this study was to investigate the effect of different formulation parameters [i.e. molecular weight and concentration of chitosan, concentration of tripolyphosphate (TPP) and use of alginate] on physico chemical and antisense properties of antisense oligonucleotide (AsODN) loaded chitosan nanoparticles (NPs). Preparation methods of phosphodiester (PO) and phosphorothioate (PS) AsODNs-NPs were also compared. AsODNI was designed to target the beta-galactosidase (beta-gal) gene. HeLa cells were used for in vitro transfection studies and beta-gal was assayed spectrophotometrically. AsODN-NPs obtained were in general positively charged with size between 221.4-525.7 nm depending on formulation. Encapsulation efficiency of NPs depended on the type of backbone of the AsODN. PO-AsODN encapsulation into NPs (78-94%) was less efficient than PS encapsulation (91-98%). The pH of the chitosan solution affected AsODN entrapment. PO-NPs exhibited faster AsODN release than NPs containing PS. In general higher beta-gal inhibition was obtained after transfection of AsODN-NPs in cell culture studies. PS-NPs exhibited a higher inhibition effect and the highest (90.71%) inhibition was obtained with formulation PT-2. PS-adsorbed NPs showed an 88% reduction in beta-gal. This study can form the basis for forthcoming in vivo studies related to AsODN carrier systems that will use chitosan.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 23 条
  • [11] Fernández-Urrusuno R, 1999, STP PHARMA SCI, V9, P429
  • [12] FERNANDEZURRUSU.R, 1999, P INT S CONTR REL BI, V26, P353
  • [13] Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides
    Fillion, P
    Desjardins, A
    Sayasith, K
    Lagacé, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1515 (01): : 44 - 54
  • [14] Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles
    Fogera, Florian
    Noonpakdee, Wilai
    Loretz, Brigitta
    Joojuntr, Songwut
    Salvenmoser, Willi
    Thaler, Marlene
    Bernkop-Schnurch, Andreas
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 319 (1-2) : 139 - 146
  • [15] Cationic polystyrene nanoparticles: Preparation and characterization of a model drug carrier system for antisense oligonucleotides
    Fritz, H
    Maier, M
    Bayer, E
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 195 (02) : 272 - 288
  • [16] Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery
    Gan, Q
    Wang, T
    Cochrane, C
    McCarron, P
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 44 (2-3) : 65 - 73
  • [17] Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector
    Gao, SY
    Chen, JN
    Dong, L
    Ding, Z
    Yang, YH
    Zhang, JF
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (03) : 327 - 334
  • [18] Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor
    Hollins, AJ
    Benboubetra, M
    Omidi, Y
    Zinselmeyer, BH
    Schatzlein, AG
    Uchegbu, IF
    Akhtar, S
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (03) : 458 - 466
  • [19] Polysaccharide colloidal particles as delivery systems for macromolecules
    Janes, KA
    Calvo, P
    Alonso, MJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) : 83 - 97
  • [20] Nanoparticulate systems for the delivery of antisense oligonucleotides
    Lambert, G
    Fattal, E
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) : 99 - 112